IMAB:US NASDAQ GM
I-Mab
AS OF 11/22/2024 CST
0.94 USD -0.02 -2.01%
OPEN
0.92
PREV CLOSE
0.96
VOLUME
276,932
MARKET CAP
0.076B
DAY RANGE
0.91 - 0.98
52 WEEK RANGE
0.90 - 2.54
About I-Mab
I-Mab operates as a clinical stage biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of novel biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab conducts business in China.
SECTOR
Health Care
INDUSTRY
Health Care
SUB-INDUSTRY
Biotech & Pharma
ADDRESS
OmniVision, 88 Shangke Road
Suite 802, West Tower
Shanghai, 201210
China
PHONE
86-21-6057-8000
WEBSITE
www.i-mabbiopharma.com
